The funding is expected to enable Tesis to increase its production capability and clinical support and allow the company to move ahead with clinical initiatives for several of its proprietary products currently going through clinical validation.
This is Tesis’ first external financing since it started in early 2020. The new sum brings the company’s total to-date funding to $35 million.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
